Pfizer criticized over patent strategy for Covid-19 pill, despite a deal to broaden access in poor countries

February 18, 2022 |
COVID inequity: In Africa, at-home tests are scarce, costly
Four ways to beat the next pandemic
Related Posts
Access to Medicines

Bad Faith from Big Pharma,...
Access to Medicines

Time to Walk Away from the...
Access to Medicines

The Quad TRIPS Waiver Text...